Cargando…
Clinical trials of antihypertensives: Nature of control and design
This paper reviews the critical issues in the control and design of antihypertension (anti-HT) clinical trials. The international guidelines and current clinical and biostatistical practices were reviewed for relevant clinical, design, end-point assessments and regulatory issues. The results are gro...
Autor principal: | Chakraborty, Bhaswat S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062112/ https://www.ncbi.nlm.nih.gov/pubmed/21455414 http://dx.doi.org/10.4103/0253-7613.75659 |
Ejemplares similares
-
Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials
por: Rygiel, Katarzyna
Publicado: (2016) -
Adaptive design clinical trials: Methodology, challenges and prospect
por: Mahajan, Rajiv, et al.
Publicado: (2010) -
Newer molecules in the treatment of schizophrenia: A clinical update
por: Ghosh, Abhishek, et al.
Publicado: (2011) -
Intricacy of missing data in clinical trials: Deterrence and management
por: Singhal, Richa, et al.
Publicado: (2014) -
Non-inferiority clinical trials: Practical issues and current regulatory perspective
por: Gupta, Sandeep K.
Publicado: (2011)